agilon health Q1 2025 revenue $1.53B, net income $12M; reaffirms FY 2025 guidance

agilon health, inc.

2026-Q1 EPS reported $0.73 vs consensus $0.95 ▼ miss (-23.0%)

Total revenue $1.53B (down 4% YoY); Medicare Advantage members 491,000 (down 6%).
Net income $12M vs loss $6M; Adjusted EBITDA $21M vs $29M.
Medical margin $128M includes $22M negative impact from prior year claims.
FY 2025 guidance: revenue $5.85-$6.025B; medical margin $275-$325M; Adj EBITDA ($95)-($55)M.
2025 gross medical cost trend estimated at 6.3% (vs 7.1% in 2024); net trend 5.3%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.